Soluble protein antigens are internalized by antigen presenting cells and processed (denatured and/or partially degraded) into peptides, which can associate with Class II molecules and activate T cells. A similar mechanism has been recently proposed for endogenously expressed, Class I restricted antigens, suggesting that antigen processing may be a general feature of MHC-restricted antigen presentation. However, a bias has been observed such that Class I restricted antigens require endogenous expression, whereas Class II molecules can associate with exogenous, internalized antigens. This difference suggests that there may be distinct pathways for antigen processing and association with Class I vs. Class II molecules. One explanation would be if Class II molecules were sequestered with recently processed exogenous antigens in an internal cellular compartment in the absence of Class I molecules. This suggestion would imply that only recently synthesized or recycled Ia molecules can associate with newly processed antigen and it raises the possibility that the interaction of Ia with invariant chain (Ii) during biosynthesis may be important or these processes. Two independent approaches will be used to test these predictions. First, Ia will be transfected with and without Ii into cells which do not express either of these molecules. In addition, Ii-negative variants will be selected from Ia, Ii-positive cells by transfection of an anti-sense RNA encoding Ii construct. These pairs of cells expressing Ia + Ii will be assayed for their ability to process and present antigen to Class II restricted T cells. Second, Ia will be placed under control of the inducible E. coli lac operator and repressor to examine the relative contribution of newly synthesized Ia compared to cell surface Ia in the association and presentation of intact antigens. Together, these experiments should determine the importance of intracellular Ia in antigen presentation.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM042071-02
Application #
3300626
Study Section
Immunobiology Study Section (IMB)
Project Start
1988-08-01
Project End
1991-07-31
Budget Start
1989-08-01
Budget End
1990-07-31
Support Year
2
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Chicago
Department
Type
Schools of Medicine
DUNS #
225410919
City
Chicago
State
IL
Country
United States
Zip Code
60637
Sevilla, L M; Richter, S S; Miller, J (2001) Intracellular transport of MHC class II and associated invariant chain in antigen presenting cells from AP-3-deficient mocha mice. Cell Immunol 210:143-53
Ashman, J B; Miller, J (1999) A role for the transmembrane domain in the trimerization of the MHC class II-associated invariant chain. J Immunol 163:2704-12
Fineschi, B; Arneson, L S; Naujokas, M F et al. (1995) Proteolysis of major histocompatibility complex class II-associated invariant chain is regulated by the alternatively spliced gene product, p41. Proc Natl Acad Sci U S A 92:10257-61
Swier, K; Miller, J (1995) Invariant chain-independent antigen presentation depends primarily upon the pool of newly synthesized MHC class II molecules. J Immunol 155:1851-61
Arneson, L S; Miller, J (1995) Efficient endosomal localization of major histocompatibility complex class II-invariant chain complexes requires multimerization of the invariant chain targeting sequence. J Cell Biol 129:1217-28
Naujokas, M F; Arneson, L S; Fineschi, B et al. (1995) Potent effects of low levels of MHC class II-associated invariant chain on CD4+ T cell development. Immunity 3:359-72
Swier, K; Miller, J (1995) Efficient internalization of MHC class II-invariant chain complexes is not sufficient for invariant chain proteolysis and class II antigen presentation. J Immunol 155:630-43
Anderson, M S; Swier, K; Arneson, L et al. (1993) Enhanced antigen presentation in the absence of the invariant chain endosomal localization signal. J Exp Med 178:1959-69
Go, C; Lancki, D W; Fitch, F W et al. (1993) Anergized T cell clones retain their cytolytic ability. J Immunol 150:367-76
Naujokas, M F; Morin, M; Anderson, M S et al. (1993) The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44. Cell 74:257-68

Showing the most recent 10 out of 13 publications